Kiora Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
KPRX
CUSIP
49721T507
Type
Equity
Class
COM
Num filings
18
Total reported value, excl. options
$4.06 M
Manager Report Date Value ($000) Shares Option Type